Paper34853296
ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling.
He Y and 10 others. Cell Death Dis, 2021. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling. Papers, record 34853296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34853296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN/AKT signaling.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AlkB Homolog 5, RNA Demethylase | Major topic |
| Membrane Glycoproteins | Major topic |
| Nerve Tissue Proteins | Major topic |
| PTEN Phosphohydrolase | Major topic |
| Pancreatic Neoplasms | Major topic |
| Potassium Channels, Tandem Pore Domain | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Disease Progression | |
| Humans | |
| Mice | |
| Signal Transduction | |
| Transfection | |
| Up-Regulation |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29351877 | REST, a master transcriptional regulator in neurodegenerative disease. | Curr Opin Neurobiol | 2018 | https://conductscience.org/library/papers/29351877 | PubMed |
| 2 | 31087222 | Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/31087222 | PubMed |
| 3 | 12860999 | MDM2 promotes ubiquitination and degradation of MDMX. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12860999 | PubMed |
| 4 | 31702028 | PTEN modulates neurites outgrowth and neuron apoptosis involving the PI3K/Akt/mTOR signaling pathway. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31702028 | PubMed |
| 5 | 27098144 | Regulation of lncRNA and Its Role in Cancer Metastasis. | Oncol Res | 2016 | https://conductscience.org/library/papers/27098144 | PubMed |
| 6 | 29753015 | LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/29753015 | PubMed |
| 7 | 31906946 | m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. | Mol Cancer | 2020 | https://conductscience.org/library/papers/31906946 | PubMed |
| 8 | 28792927 | Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. | Nature | 2017 | https://conductscience.org/library/papers/28792927 | PubMed |
| 9 | 31774983 | Pancreatic cancer: An update on diagnosis and management. | Aust J Gen Pract | 2019 | https://conductscience.org/library/papers/31774983 | PubMed |
| 10 | 32630372 | The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32630372 | PubMed |
| 11 | 31713929 | miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway. | Cell Prolif | 2020 | https://conductscience.org/library/papers/31713929 | PubMed |
| 12 | 28030829 | CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer. | Oncotarget | 2017 | https://conductscience.org/library/papers/28030829 | PubMed |
| 13 | 31041193 | Identification of RE1-Silencing Transcription Factor as a Promoter of Metastasis in Pancreatic Cancer. | Front Oncol | 2019 | https://conductscience.org/library/papers/31041193 | PubMed |
| 14 | 19188922 | Long non-coding RNAs: insights into functions. | Nat Rev Genet | 2009 | https://conductscience.org/library/papers/19188922 | PubMed |
| 15 | 31788071 | Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31788071 | PubMed |
| 16 | 31900915 | Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31900915 | PubMed |
| 17 | 31572012 | Epigenetic regulation of IncRNA KCNKI5-ASI in gastric cancer. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31572012 | PubMed |
| 18 | 24480744 | Methylation modifications in eukaryotic messenger RNA. | J Genet Genomics | 2014 | https://conductscience.org/library/papers/24480744 | PubMed |
| 19 | 31581133 | KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31581133 | PubMed |
| 20 | 30784918 | The role of m6A RNA methylation in cancer. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30784918 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42491192 | m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42491192 | PubMed |
| 42021253 | The RNA methylation modification as an immunometabolic regulatory hub in pancreatic cancer: from mechanistic insights to clinical translation perspectives. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42021253 | PubMed |
| 41789626 | Pancreatic cancer EMT‑targeted therapy: Molecular mechanisms and clinical translation (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41789626 | PubMed |
| 41607610 | The epitranscriptome meets non-coding RNA: m6A-mediated regulation in oncogenesis and therapy. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41607610 | PubMed |
| 41423400 | Targeting ion channel dysregulation in tumors: emerging therapeutic opportunities. | Trends Pharmacol Sci | 2026 | https://conductscience.org/library/papers/41423400 | PubMed |
| 41390849 | Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. | Nat Commun | 2025 | https://conductscience.org/library/papers/41390849 | PubMed |
| 41301491 | Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301491 | PubMed |
| 41023574 | Hypermethylated Long Non-Coding RNA Genes KCNK15-AS1, MAGI2-AS3, and SSTR5-AS1 in Ovarian Cancer and Their Diagnostic Potential. | Bull Exp Biol Med | 2025 | https://conductscience.org/library/papers/41023574 | PubMed |
| 40760661 | Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40760661 | PubMed |
| 40675967 | Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40675967 | PubMed |
| 40481562 | Biological interpretation of DNA/RNA modification by ALKBH proteins and their role in human cancer. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40481562 | PubMed |
| 40448344 | Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer. | Cancer Med | 2025 | https://conductscience.org/library/papers/40448344 | PubMed |
| 40371134 | Role and mechanisms of m6A demethylases in digestive system tumors. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/40371134 | PubMed |
| 40356909 | Epigenetic regulation in oogenesis and fetal development: insights into m6A modifications. | Front Immunol | 2025 | https://conductscience.org/library/papers/40356909 | PubMed |
| 40271153 | Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40271153 | PubMed |
| 40205638 | Role of noncoding RNA and protein interaction in pancreatic cancer. | Chin Med J (Engl) | 2025 | https://conductscience.org/library/papers/40205638 | PubMed |
| 39967906 | The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions. | EXCLI J | 2025 | https://conductscience.org/library/papers/39967906 | PubMed |
| 39933650 | Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer. | J Adv Res | 2025 | https://conductscience.org/library/papers/39933650 | PubMed |
| 39904996 | Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/39904996 | PubMed |
| 39611478 | Role of the m6A demethylase ALKBH5 in gastrointestinal tract cancer (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39611478 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34853296
GET https://conductscience.org/api/papers/v1/34853296/references?page=2